WHITESBURG, Ky. — Drugs and the consequences of addiction are woven into the fabric of Jamie Madden’s life. Her earliest memory is of standing on the passenger seat of her dad’s car as a toddler, wearing a peach-colored blouse, while he drove from their Kentucky home to Florida to pick up drugs. On a stop…
Sen. Ron Wyden and 14 Democratic co-sponsors plan to introduce legislation Thursday to cap consumers’ potential out-of-pocket costs in traditional Medicare, resurfacing a long-running debate over why the program doesn’t limit beneficiary spending. Even the bill’s backers say securing passage this year is a long shot. But the effort is one more opportunity for Democrats…
By MICHAEL MILLENSON It took 129 years for the inalienable rights proclaimed in America’s Declaration of Independence to apply to the rights of patients in relationship to their doctors. In 1905, an Illinois appellate court ruled in favor of a woman who’d sued her surgeon for performing a hysterectomy without disclosing in advance what procedure…
Gilead Sciences antibody drug conjugate Trodelvy is now approved as a first-line treatment for triple-negative breast cancer. This expanded approval for Trodelvy comes with a slightly broader label that gives it an edge over the AstraZeneca and Daiichi Sankyo ADC Datroway. The post New FDA Nod Keeps Gilead Drug Competitive With AstraZeneca & Daiichi in…
Priority Health is partnering with Garner Health to steer members to high-quality physicians and reduce healthcare costs for employers. The post New Partnership Aims to Lower Out-of-Pocket Costs, Even Eliminate Them In Some Cases appeared first on MedCity News.
Women’s health platform Xella Health launched with a $499-per-year membership. The platform provides women the kind of connected healthcare that has typically only been available through expensive concierge medicine, said CEO Kelly Lacob. The post Xella Health Emerges from Stealth to Give Women Answers the Healthcare System Hasn’t appeared first on MedCity News.
There is no excerpt because this is a protected post.
There is no excerpt because this is a protected post.
That is the title of my new Health Affairs Forefront piece out today with Lou Garrison and Richard Xie. An excerpt from the article is below: United States policy makers increasingly argue that Americans pay too much for prescription drugs. In a recent report, the Senate Health, Education, Labor, and Pensions (HELP) Committee minority staff contended…
Successful AI adoption in healthcare depends on scalable infrastructure, trust-building through transparency, and the integration of advanced AI capabilities like multi-agent systems to support complex clinical workflows and improve outcomes.